BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Enveric Biosciences Inc (NASDAQ:ENVB)

1 post

Biotech NewsEnveric Biosciences (ENVB) Reports Breakthrough PTSD Results as EB-003 Moves Toward IND in 2026

  • BioTech Health X
  • December 5, 2025
Enveric Biosciences Inc (NASDAQ:ENVB) is a biotechnology company built on a scientific foundation of developing next-generation neuroplastogenic therapeutics…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • The IPO Everyone Missed: Why Medline (MDLN) Could Become the “Costco of Healthcare Supplies”
  • This Side of Healthcare Gets Paid No Matter What the Economy Does
  • Investors Keep Chasing Hype — But Healthcare’s Real Cash Machines Are Right Here
  • Here’s Why Healthcare Equipment and Services Keep Winning Even When Markets Panic
  • This Biotech Keeps Raising Red Flags — Why Coeptis Therapeutics (COEP) Looks More Like a Warning Than an Opportunity
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • January 30, 2026
    The IPO Everyone Missed: Why Medline (MDLN) Could Become the “Costco of Healthcare Supplies”
    • January 30, 2026
    This Side of Healthcare Gets Paid No Matter What the Economy Does
    • January 30, 2026
    Investors Keep Chasing Hype — But Healthcare’s Real Cash Machines Are Right Here
    • January 29, 2026
    Here’s Why Healthcare Equipment and Services Keep Winning Even When Markets Panic
    • January 28, 2026
    This Biotech Keeps Raising Red Flags — Why Coeptis Therapeutics (COEP) Looks More Like a Warning Than an Opportunity
Recent Posts
  • Elevance Health (ELV) Touches Millions Every Day — Yet it Rarely Makes Headlines
    • January 28, 2026
  • This 120-Year-Old Pharma Giant Is Suddenly Hot Again — Teva Pharmaceutical (TEVA)
    • January 28, 2026
  • From Hospitals to Medicare Dominance: How Humana (HUM) Built a Healthcare Empire
    • January 28, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (750)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top